ACCENTURE PLC

Accenture insiders sell via 10b5‑1: Unruch Joel liquidates 12,748 shares at a premium, showing routine liquidity management amid steady growth.

Insider buying at Accenture shows confidence amid market volatility—top execs are buying shares, hinting at an undervalued stock and potential rebound.

Egawa Atsushi’s April 2026 10b5‑1 sale of 5,911 Accenture shares—timed after a sharp dip—signals a strategic shift in Asia Pacific’s outlook, urging investors to weigh insider buying vs. selling, partnership growth, and market sentiment.

Accenture CEO Sweet Julie Spellman sold 1,843 shares in Feb‑23, signaling possible over‑valuation; investors should watch her next moves for a clear growth or caution cue.

Accenture insider sales spike: top execs sell 30K+ shares, hinting at confidence worries amid a 39% yearly drop—investors eye potential buying opportunities.

Accenture insider buying signals a cautious optimism: senior executives, including Unruch Joel, are buying Class A shares amid a new federal contract and AI focus, suggesting confidence and potential stability for investors.

Accenture CEO’s February 4 insider sales show disciplined, rule‑based trading amid AI growth, reassuring investors that gains are locked in, not a warning sign.

Accenture insider sells reveal a steady, low‑volume trading plan—no panic, just strategic portfolio rebalancing that keeps the stock’s resilience intact.

Accenture CFO Park Angie Y sells 602 shares amid a bullish rally; the move reflects routine liquidity, not a red flag for investors.

Insider buying spurs optimism for Accenture’s AI‑driven growth. Learn how Sarin Arun’s share grant signals long‑term confidence amid market swings.